| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82531 |
DOTA-TATE ， DOTA-3-酪氨酰基-奥曲肽 , 177943-89-4 |
172 |
wyh |
2024-11-29 |
| 82532 |
2570254-31-6，Pomalidomide-C3-I |
91 |
kx |
2024-11-29 |
| 82533 |
1262403-91-7 , 七肽DOTA-YLYEIAR |
104 |
wyh |
2024-11-29 |
| 82534 |
DOTA-amide dihydrate；DOTA酰胺二水合物 |
102 |
zcy |
2024-11-29 |
| 82535 |
RGD,[18F]FB-c(RGDyK) , N-4-[18F]Fluorobenzoyl-c(RGDyK |
111 |
wyh |
2024-11-29 |
| 82536 |
1262403-90-6 , 七肽DOTA-VLASSAR |
96 |
wyh |
2024-11-29 |
| 82537 |
486429-99-6，(S)-C3-TunePhos |
109 |
kx |
2024-11-29 |
| 82538 |
海藻酸钠-聚乙二醇-大环配体 ；alginate-PEG-DOTAM |
133 |
wyh |
2024-11-29 |
| 82539 |
DOTA-三叔丁酯-叠氮 ；DOTA-(COOt-Bu)3-azide |
142 |
wyh |
2024-11-29 |
| 82540 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 DOTA-PEG5-C4-DBCO |
110 |
zcy |
2024-11-29 |
| 82541 |
1539292-60-8，APN-C3-NH-Boc |
113 |
kx |
2024-11-29 |
| 82542 |
DOTA-cyclo(Arg-Gly-Asp-DPhe-Lys) |
103 |
wyh |
2024-11-29 |
| 82543 |
DOTA-TMTP1的性质与应用 |
90 |
wyh |
2024-11-29 |
| 82544 |
DOTA-三聚乙二醇-叠氮(盐酸盐) DOTA-PEG3-azide(HCl) 1428146-79-5 |
91 |
zcy |
2024-11-29 |
| 82545 |
7-R-7-磷杂降冰片二烯M(CO)5(M=Mo,W)配合物 |
179 |
h |
2024-11-29 |
| 82546 |
DOTA-cyclo(RGDfK) ；DOTA-RGD |
139 |
wyh |
2024-11-29 |
| 82547 |
2376146-48-2，ZN-c3 |
107 |
kx |
2024-11-29 |
| 82548 |
Mem-Tz-Rh 四嗪与罗丹明结构连接溶酶体靶向探针 |
152 |
WYQ |
2024-11-29 |
| 82549 |
Mito-Tz-BDP Bodipy与四嗪共轭连接线粒体靶向探针 |
207 |
WYQ |
2024-11-29 |
| 82550 |
3-三氟甲基-6-硝基胍基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪化合物 |
122 |
WYQ |
2024-11-29 |
| 82551 |
DOTA-「Tyr3」-Octreotide , DOTA-(酪氨酸3)-奥曲肽 |
84 |
wyh |
2024-11-29 |
| 82552 |
1,4-二吡唑基-2,3,5,6-四嗪构筑的金属有机框架 |
127 |
WYQ |
2024-11-29 |
| 82553 |
1,4-二-(吡唑基)-2,3,5,6-四嗪修饰三氟甲基磺酸锌[Zn(bptz)2]n |
172 |
WYQ |
2024-11-29 |
| 82554 |
3,6-二(4-吡啶基)-1,2,4,5-四嗪 |
88 |
WYQ |
2024-11-29 |
| 82555 |
DOTA-PEG4-MeTz DOTA-PEG4-甲基四嗪 甲基四嗪聚乙二醇大环化合物 |
140 |
zcy |
2024-11-29 |
| 82556 |
5966-29-0；N-棕榈酰-D-赤型-鞘氨醇；C16 Dihydroceramide (d18:0/16:0) |
355 |
kx |
2024-11-29 |
| 82557 |
p-SCN-Bn-DOTA ；2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
93 |
wyh |
2024-11-29 |
| 82558 |
DOTA-Suc-Lys-(FAPI-04)2 3029114-60-8 DOTA-琥珀酰基-赖氨酸-(FAPI-04)2 |
106 |
zcy |
2024-11-29 |
| 82559 |
913528-04-8 , DOTAM-mono-acid-CSDN |
74 |
wyh |
2024-11-29 |
| 82560 |
降冰片烯单体[5-降冰片烯-2-亚甲氧基-4-己氧基联苯(PhHN)] |
152 |
h |
2024-11-29 |
| 82561 |
Tm-DOTA , DOTA大环化合物 |
86 |
wyh |
2024-11-29 |
| 82562 |
四嗪基UIO-66金属有机骨架 |
267 |
WYQ |
2024-11-29 |
| 82563 |
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) 定制 |
107 |
zcy |
2024-11-29 |
| 82564 |
四嗪功能基团修饰寡聚(p-苯撑乙炔)分子 |
136 |
WYQ |
2024-11-29 |
| 82565 |
icariside C3，CAS号：108906-48-5 |
146 |
zyl |
2024-11-29 |
| 82566 |
1,2,4,5-四嗪-3,5-双(1H-1,2,4-三唑-3-硝胺基) |
123 |
WYQ |
2024-11-29 |
| 82567 |
DOTA-tris(acid)-amido-dPEG®11-Maleimide；DOTA-聚乙二醇（dPEG）间隔基-马来酰亚胺 |
112 |
zcy |
2024-11-29 |
| 82568 |
3-三氟甲基-6-氨基[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪类含能化合物 |
94 |
WYQ |
2024-11-29 |
| 82569 |
DOTA-(Tyr3)-Octreotate ，DOTA-3-酪氨酰基-奥曲肽 |
68 |
wyh |
2024-11-29 |
| 82570 |
N-(3-(三氟甲基)-[1,2,4]三唑并[4,3-b][1,2,4,5]四嗪)硝酸酰胺 |
138 |
WYQ |
2024-11-29 |
| 82571 |
TCO-C3-PEG3-C3-amine，cas:2028288-77-7，反式环辛烯-C3-三聚乙二醇-C3-氨基 |
127 |
zyl |
2024-11-29 |
| 82572 |
Maleimide-DOTA-GA 马来酰亚胺-DOTA-镓 大环配体化合物 |
176 |
zcy |
2024-11-29 |
| 82573 |
Mem-Tz-Rh 四嗪与罗丹明结构连接溶酶体靶向探针 |
204 |
WYQ |
2024-11-29 |
| 82574 |
Mito-Tz-BDP Bodipy与四嗪共轭连接线粒体靶向探针 |
160 |
WYQ |
2024-11-29 |
| 82575 |
DOTA标记的双c(RGDfK)环肽 |
122 |
wyh |
2024-11-29 |
齐岳微信公众号
官方微信
库存查询